Navigation Links
Cardiac in Medical Technology

NewCardio Announces Master Services Agreement With Dedicated Phase I

... -- NewCardio, Inc., (OTC Bulletin Board: NWCI) a cardiac diagnostic and services company, today announced ... analysis of QT intervals and other ECG-based cardiac safety for the pharmaceutical industry and drug ... automated analysis of ECGs used to determine cardiac toxicity during drug development. About ...

2,500 Cases Completed With the Magnetic Irrigated Catheter

... cases has been exceptional. The major adverse cardiac event rate for magnetic procedures remains at ... These include ablations of a wide variety of cardiac arrhythmias in all four chambers of the heart and ... technology as a platform for all manner of cardiac and vascular interventions," said Michael P. ...

Treatment Shows Excellent Results for Providence Tarzana Patients Following Cardiac Arrest

... Therapeutic hypothermia treatment, where cardiac arrest patients are cooled to 92 degrees, is ... recovery of neurologic function after prolonged cardiac arrest," said G. Scott Brewster, M.D., medical ... with the process so that anyone who has a cardiac arrest in the local community or arrests in the ...

World's First Cardiac Adult Stem Cell Patient Receives Infusion

... has become the world's first recipient of adult cardiac stem cells to treat congestive heart failure. ... phase-one FDA-approved clinical trial using adult cardiac stem cells to treat heart disease. The clinical ... Jones was directly injected with his own cardiac stem cells into heart scar tissue using a ...

Injection Reverses Heart-Attack Damage

... improves heart function without need for cardiac stem cells BOSTON, July 23 ... can spur heart-muscle growth and recovery of cardiac function when injected systemically into animals ... also lacked the left-ventricular dilation and cardiac hypertrophy that typify heart failure; both were ...

Poniard Pharmaceuticals Announces Positive Cardiac Safety Data From Picoplatin Phase 1 Trial Supporting NDA Filing

... therapies, today announced results from a Phase 1 cardiac safety study of picoplatin, a new generation ... entities. This study evaluated the cardiac safety of picoplatin by determining its effect on the cardiac QT/QTc interval by using time-matched ...

St. Francis Surgeon Uses Tissue Regeneration Technology to Rebuild Patients' Heart Structures

... Matrix (ECM)(TM) to modify and repair cardiac structures, allowing heart tissue to re-grow ... use of this biomaterial is a major advancement in cardiac surgery and allows us to provide our patients ... structures. It opens the door to a new level of cardiac tissue reconstruction," said Gerdisch, director ...

New Therapy Found to Prevent Heart Failure

... with heart disease who received an implanted cardiac resynchronization therapy device with ... versus patients who received only an implanted cardiac defibrillator (ICD-only). MADIT-CRT ... Automatic Defibrillator Implantation Trial with cardiac Resynchronization Therapy) is a clinical trial ...

Responses After Completion of Therapy Increase Pixantrone Complete Remission (CR)/Unconfirmed Complete Remission (CRu) Rate to 24% and Overall Response Rate (ORR) to 40% Compared to 7% and 14% for Comparator Agents in Phase III EXTEND Trial in 3rd Line Th

... study arms (18% vs. 13%). Although the grade 3, 4 cardiac disorder was similar among the two treatment ... there was a slightly higher incidence of serious cardiac disorders in patients treated with pixantrone ... agents (8.8% vs. 4.5%). Events considered cardiac disorders ...

Isis Highlights New Data on Antisense Drugs to Treat Type 2 Diabetes and Obesity at ADA Scientific Sessions

... sensitivity with associated improvement in cardiac glucose metabolism. These data suggest that RBP4 ... target for type 2 diabetes and associated cardiac disease. In addition to new data ... and Peripheral Insulin Sensitivity and Improves cardiac Glucose Uptake in Diet-Induced Obese Mice ...

Two New Clinical Studies Show That Limited Exposure to Blood Transfusion Significantly Increases Morbidity and Mortality After Surgery

... and another conducted in patients undergoing cardiac surgery and published in the Anesthesia & ... risk by 38% and morbidity risk by 40%. In the cardiac surgery study, researchers evaluated long-term ... and Decreased Long-Term Survival After cardiac Surgery. Anesthesia & Analgesia 2009; ...

New Heart Ultrasound Research Reveals Life-Saving Treatment Alternatives and Advancements for Heart Patients

... can better predict potentially life-threatening cardiac events with real-time, three-dimensional ... is a professional organization of physicians, cardiac sonographers, nurses and scientists involved in ... has is the largest international organization for cardiac imaging. For more information on ASE, visit ...

Heparin Use Prior to Endoscopic Vein Harvest Improves Graft Patency in Off-Pump Coronary Artery Bypass Patients

... Robert Poston, M.D., Chief, Division of cardiac Surgery, Boston University . The ... said Pat Walsh, Chief Operating Officer of the cardiac Surgery division of MAQUET. "As a leader in EVH, ... with Boston Scientific's Vascular Surgery and cardiac Surgery divisions, which includes the products ...

Pixantrone in Combination with Chemotherapy Regimens Produces Overall Response Rates of 58-74% with Complete Remission Rates of 37-57% in Relapsed/Refractory Aggressive or Indolent NHL

... early clinical studies pixantrone exhibited lower cardiac toxicity and better anti-tumor activity than that ... anthracyclines, as it is devoid of the putative cardiac toxicity generating chemical structure," said ... a low cardiotoxicity profile or to produce low cardiac toxicity, the failure of pixantrone to produce ...

SCAI Statement on the BARI 2D Trial (Bypass Angioplasty Revascularization Investigation With Diabetes Trial) Presented at the American Diabetes Association (ADA) Annual Scientific Sessions and Published in The New England Journal of Medicine

... said Robert Chilton, DO, Director of the cardiac Catheterization Laboratory, South Texas VA ... study," said Robert Chilton, DO, Director of the cardiac Catheterization Laboratory, South Texas VA ... said Robert Chilton, DO, Director of the cardiac Catheterization Laboratory, South Texas VA ...

Cardiogenesis Announces Presentation of its PHOENIX(R) Combination TMR Plus Stem Cell Delivery System at the International Society of Minimally Invasive Cardiothoracic Surgeons (ISMICS) Annual Meeting

... (TMR) for the treatment of chronic cardiac ischemia, announces that Dr. Naresh Trehan of New ... and has been used in over 50 procedures at cardiac centers outside the U.S. It is not currently FDA ... in the therapies for the treatment of chronic cardiac ischemia. The company's market leading ...

Pixantrone Produces High Rates of Complete and Partial Remissions Even Among Aggressive NHL Patients With Extensive Prior Doxorubicin Treatment or Prior Rituximab Treatment

... typically not to be used due to a high risk of cardiac toxicity, including cardiac failure. Twenty-five of the 70 patients in ... numerically higher, the overall incidence of cardiac events were lower than expected in this patient ...

Celladon Provides MYDICAR(R) Program Update of First-In-Human Trial for Advanced Heart Failure at American Society of Gene Therapy Annual Meeting

... by Percutaneous Administration of Gene Therapy in cardiac Disease (CUPID), a First-in-Human Phase 1/2 ... are encouraged by the meaningful improvements in cardiac function and overall condition of patients, ... and validated the overall beneficial effects on cardiac function. MYDICAR is a recombinant ...

Video: Data on More Than 15 Novartis Oncology Compounds at ASCO Highlight Progress Toward Targeted Therapies for Diverse Tumor Types

... drop in platelets count, diarrhea, bleeding, cardiac ischemia, elevated liver function tests and ... been reported. Most of the patients with reported cardiac events have had other comorbidities and risk ... advanced age and previous medical history of cardiac disease. Patients ...

MitraClip(R) Therapy Data Demonstrate Clinical Benefit in High-Risk Patients With Mitral Regurgitation

... Registry Data Show Improved Symptomatic Status, cardiac Function and Reduced rate of Hospitalization for ... by Saibal Kar, M.D., director of interventional cardiac research at Cedars-Sinai Medical Center and the ... system which enables percutaneous repair of cardiac valves. The company's initial products are ...

PLC Medical Systems to Demonstrate RenalGuard(R) at EuroPCR 2009

... Board: PLCSF), a company focused on innovative cardiac and vascular medical device-based technologies, ... in the prevention of CIN in patients undergoing cardiac catheterization procedures and percutaneous ... specializing in innovative technologies for the cardiac and vascular markets. Headquartered in Franklin, ...

TYRX Presents Early Clinical Results from AIGISRX(TM) Antibacterial Envelope Retrospective Registry

... of infection, in patients implanted with cardiac rhythm management device (CRMD) and the AIGIS. ... published historical and case-matched controls of cardiac rhythm management device (CRMD) recipients. TYRX ... a majority of the infections reported in cardiac rhythm device related endocarditis, including ...

Boston Scientific Data Show Real-World Survival Rates for Implantable Cardiac Device Patients Exceed Rates From Clinical Trials

... show real-word survival rates for implantable cardiac device patients exceeding rates from clinical ... cardioverter defibrillators (ICDs) and cardiac resynchronization therapy defibrillators (CRT-Ds) ... 2006, making it the most rapidly adopted remote cardiac device monitoring system in the industry(1). The ...

NewCardio Leadership to Present Two Abstracts at ISCE Conference

... Accurate, Fully Automated ECG Analysis for Drug cardiac Safety at 34th Annual ISCE Meeting SANTA ... -- NewCardio, Inc., (OTC Bulletin Board: NWCI) a cardiac diagnostic and services company, today announced ... May Adversely Affect Final Results In cardiac Safety Studies," authored by Drs. Branislav ...

Impulse Dynamics Announces Pivotal Results at the American College of Cardiology Annual Meeting Late-Breaking Session

... safety and efficacy of the OPTIMIZER System's cardiac contractility modulation (CCM) signals when ... esandoval@lazarpartners.com . About cardiac Contractility Modulation (CCM) Therapy cardiac Contractility Modulation is a new treatment for ...

Abbott's Market-Leading XIENCE V(R) Shows Increasing Clinical Advantages Over TAXUS(R) Express2(TM)/TAXUS(R) Liberte(TM) Between Two and Three Years

... Including an 88 Percent Reduction in the Risk of cardiac Death at Three Years ORLANDO, Fla., March 29 ... Abbott's market-leading XIENCE V maintained a low cardiac death rate of 0.5 percent, while the observed cardiac death rate for TAXUS more than tripled during the ...

MitraClip(R) Therapy Data Shows Important Clinical Benefit in High Risk Patients With Functional Mitral Regurgitation at 12-Month Follow Up

... Data Shows Improved Symptomatic Status and cardiac Function in Functional MR Patients Treated with ... today by Ted Feldman, M.D., director of the cardiac catheterization lab at Evanston North Shore ... of Thoracic Surgery Mortality Risk Model, or by a cardiac surgeon's determination that one or more ...

RenalGuard(R) Pilot Safety Clinical Trial Data to be Presented at ACC 2009

... Board: PLCSF), a company focused on innovative cardiac and vascular medical device-based technologies, ... trial was Dr. Frederic S. Resnic, Director of the cardiac Catheterization Lab at Brigham and Women's ... specializing in innovative technologies for the cardiac and vascular markets. Headquartered in Franklin, ...

Innocoll Announces Dosing of Last Patient in US Phase 3 Clinical Trial to Investigate GENTAMICIN SURGICAL IMPLANT for Prevention of Surgical Site Infections in Cardiac Surgery Patients

... and/or obese (BMI>30) patients undergoing cardiac surgery. Such patients are generally recognized ... and potentially life-threatening complication of cardiac surgery. Patients in the treatment group have two ... have completed patient enrolment in this phase 3 cardiac surgery trial, which we are running in parallel ...

First Swiss Patients Treated with the Percutaneous MitraClip(R) System

... of devices for the percutaneous repair of cardiac valves, announced today that the first series of ... poor life-expectancy. Implantable devices such as cardiac resynchronization therapy have improved the ... MitraClip device in Switzerland at this important cardiac center," said Ferolyn Powell, president and chief ...

From eResearchTechnology to ERT

... for ERT's industry-leading products and services: cardiac Safety Solutions; EDC Solutions; ePRO Solutions and ERT Clinical Research Consulting Group. cardiac Safety, EDC and ePRO Solutions are founded upon ... (ECG) technology and services to evaluate cardiac safety in clinical development. The company is ...

New England Journal of Medicine Publishes Results from Boston Scientific's Landmark SYNTAX(TM) Trial

... Ted Feldman, M.D., F.S.C.A.I., Director of the cardiac Catheterization Laboratory at NorthShore ... including an interventional cardiologist and a cardiac surgeon. If both the cardiologist and surgeon ... in the PCI registry had been rejected for cardiac surgery, and patients in the CABG registry had ...

First U.S. Patients Enrolled in the REALISM Continued Access Study

... of devices for the percutaneous repair of cardiac valves, announced today the start of enrollment ... REALISM study," said Dr. Fail, director of the cardiac catheterization lab and principal investigator at ... said Ted Feldman, M.D., director of the cardiac catheterization lab at Evanston Hospital and ...

New Research Suggests Platelet 'Stickiness' May be the Single Most Important Risk Factor in Patients Treated with Coronary Stents - Findings May be Applicable to Anyone with Vascular Disease

... Gurbel's findings may explain why someone with no cardiac history could die suddenly of a massive heart ... and plaque-filled arteries may never have a cardiac event because they had low platelet aggregation. ... respond to treatment. "Of the millions of cardiac patients treated with clopidogrel, a significant ...

Circulation Publishes Pivotal Two-Year Results On XIENCE V(TM) Drug Eluting Stent

... MACE, and a 40 percent reduction in the risk of cardiac death or heart attack (myocardial infarction, or ... and efficacy outcomes for patients, defined as cardiac death, MI or ischemia-driven target ... -- A 40 percent reduction in the risk of cardiac death or MI (4.0 percent for XIENCE V vs. 6.6 ...

Mardil Inc. Advances Its Novel Cardiac Device to First-In-Human Trials for Mitral Valve Regurgitation

... N.C., Jan. 26 /PRNewswire/ -- Mardil Inc., a cardiac device company with novel technology for treating ... Raman, professor of surgery and director of adult cardiac surgery and cardiothoracic surgical research at ... design, develop and market innovative, patented cardiac technologies. Each technology will fulfill a ...

Wrist Access Safer, Easier for Many Patients Undergoing Minimally Invasive Treatment of Blocked Heart Arteries

... more than 5,000 procedures performed at Baptist cardiac & Vascular Institute, Miami. The radial ... director of interventional cardiology at Baptist cardiac & Vascular Institute, and ISET course ... failure, blood infection and death. At Baptist cardiac & Vascular Institute, the complication rates ...

Pfizer Contributes Critical Data to URMC Drug Safety Initiative

... catalogue of continuous recordings from both cardiac patients and healthy individuals and is available ... because of its adverse effect of the process of cardiac ventricular repolarization - the split-second ... believed to heighten the risk for adverse cardiac events, such as dangerous arrhythmias and heart ...

Study Finds DOXIL(R) Combination Therapy Delays Disease Progression for Patients With Metastatic Breast Cancer

... the incidence of symptomatic cardiac events was 5% in the combination group versus 4% ... for metastatic breast cancer, but concerns about cardiac toxicity have prevented oncologists from using ... * The use of DOXIL may lead to cardiac toxicity. Myocardial damage may lead to ...

Video: Tasigna(R) Demonstrates Rapid Response as Initial Therapy in Life-Threatening Form of Leukemia

... been reported. Most of the patients with reported cardiac events have had other co-morbidities and risk ... advanced age and previous medical history of cardiac disease. Patients with cardiac disease or risk factors ...
Other Contents
(Date:4/2/2015)... Md. , April 2, 2015 At ... Salt Lake City , the American College ... of five new directors to its Board.  Members of ... the ACMG and for forming and advancing its policies ... medical genetics profession. "It,s an eventful time ...
(Date:4/2/2015)... 2, 2015 Fingerprint Cards (FPC) ... FPC1025 from the distributor World Peace Industrial Group (WPI), ... 2015 although the major part of the shipments will ... used by smartphone manufacturers in China ... in the communicated revenue guidance of + 1 000 MSEK ...
(Date:4/1/2015)... BOSTON , April 1, 2015   Medisafe ... 1.5 million users across iOS and ... has begun integrating biofeedback into the platform to allow ... health outcomes. For the first time, patients will be ... missing a dose impacts important biometrics, such as glucose ...
Breaking Biology News(10 mins):American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 2American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 3American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 4American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 5American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 6American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 7American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 8Fingerprint Cards Receives Touch Fingerprint Sensor Order of SEK 110 Million 2Medisafe Announces Launch of Biometric Integration, Enabling Patients to Stay Adherent to Their Meds and See Tangible Health Results 2
(Date:4/19/2015)... Insurancecarsinsurance.com has released a new blog post making weather ... can affect auto insurance premiums . , ... insurance premiums. In some Northern states like Wisconsin, due ... in other parts. The newly released blog post explains ... months and what impact, if any, it will have ...
(Date:4/19/2015)... McCann Investigations, a Texas-based full services private investigations ... paper Married, but Dating: The Rise of the ... a unique environment of privacy, anonymity and unlimited access, ... spouses has emerged. Social platforms which have been created ... online. Dating sites and mobile apps have found ...
(Date:4/18/2015)... April 19, 2015 For some people, tattoos ... display for the rest of their lives, as they have ... and put in a great amount of thought on their ... they have outgrown them or simply want them removed for ... regret their tattoo, and in 2012-13 there was a 43 ...
(Date:4/18/2015)... April 18, 2015 Carinsurancesavings.biz has released ... plans are cheaper during Spring. , Spring ... insurance plan. Drivers should make sure they compare the ... vehicles. Clients can learn more about Spring car insurance ... , Auto insurance quotes are becoming more and more ...
(Date:4/18/2015)... (PRWEB) April 18, 2015 Review of ... hosting a ‘Strategies for Success’ program for cataract surgeons ... meeting in San Diego, where eye surgeon Jeffrey L. ... this invitation-only event. Dr. Martin is the Managing Partner ... of Ophthalmology chose Dr. Martin to lead this year’s ...
Breaking Medicine News(10 mins):Health News:Bad Weather Can Cause Accidents and Affect Auto Insurance Prices! 2Health News:McCann Investigations Publishes White Paper Married, but Dating: The Rise of the Married Online Affair 2Health News:Dennis Dass, M.D. is Shattering the Past While Revealing the Future 2Health News:Auto Insurance Plans Are Cheaper During Spring! 2Health News:Dr. Jeffrey Martin Invited to Share Latest Breakthroughs in Cataract Care During Roundtable Discussion at National 2015 ASCRS Meeting In San Diego 2
Other TagsOther Tags